ミトコンドリア標的型ナノデバイス “MITO-Porter” の創製

  • 山田 勇磨
    北海道大学大学院薬学研究院薬剤分子設計学研究室

書誌事項

タイトル別名
  • Development of the MITO-Porter, a Nano Device for Mitochondrial Drug Delivery <i>via</i> Membrane Fusion
  • ミトコンドリア ヒョウテキガタ ナノデバイス"MITO-Porter"ノ ソウセイ

この論文をさがす

抄録

  Many human diseases have been reported to be associated with mitochondrial dysfunction. Therefore, mitochondrial therapy would be expected to be useful and productive in the treatment of various diseases. To achieve such an innovative therapy, it will be necessary to deliver therapeutic agents into mitochondria. However, only a limited number of methods are available for accomplishing this. We previously developed the MITO-Porter, a liposome-based carrier that permits macromolecular cargos to be transported into mitochondria via membrane fusion. Intracellular observations using the green fluorescence protein as a model macromolecule confirmed the mitochondrial delivery of a macromolecule by the MITO-Porter. Moreover, when we attempted the mitochondrial delivery of bongkrekic acid (BKA), an antiapoptosis agent, the MITO-Porter enhanced the antiapoptosis effect compared with naked BKA. To construct a device with enhanced performance, the MITO-Porter was coated with cell membrane-fusogenic outer envelopes to produce the dual function (DF)-MITO-Porter. Intracellular observations indicated that the DF-MITO-Porter was more effective in delivering exogenous macromolecules into mitochondria than the conventional MITO-Porter. Furthermore, when biomacromolecules were delivered using the DF-MITO-Porter to estimate the mitochondrial gene targeting of the carrier, the results confirmed that the MITO-Porter system has the potential for use in therapies aimed at mitochondrial DNA. This paper sumarizes our findings on mitochondrial drug delivery systems that are directed toward mitochondrial medicine development and mitochondrial gene therapy. It is expected that the MITO-Porter system will open new research areas in mitochondrial drug delivery systems and have a significant impact on the medical and life sciences.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 134 (11), 1143-1155, 2014-11-01

    公益社団法人 日本薬学会

被引用文献 (1)*注記

もっと見る

参考文献 (38)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報

問題の指摘

ページトップへ